[RDHL] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
19-Nov-2019
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -18.87%
YoY- -52.15%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 12,798 22,071 21,461 1,590 1,359 2,001 100 124.40%
PBT -3,729 -24,373 -24,331 -11,691 -7,684 -10,413 -8,349 -12.56%
Tax -6,219 -81 -378 212 -364 -787 1,013 -
NP 2,490 -24,373 -24,331 -11,691 -7,684 -10,413 -8,349 -
Tax Rate - - - - - - - -
Total Cost 10,308 46,444 45,792 13,281 9,043 12,414 8,449 3.36%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 19.46 -110.43 -113.37 -735.28 -565.42 -520.39 -8,349.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 1.07 -19.65 -25.69 -13.89 -11.68 -20.70 -24.00 -
EPS Diluted 1.07 -19.65 -25.69 -13.89 -11.68 -20.00 -24.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.